Additionally, the transwell assay revealed a substantial decrease in migrating and invasive NSCLC cells after 24 h of treatment with SORT1 siRNA compared to the control group (Figure 3B,C). This evidence concerns the gene SORT1 and non-small cell lung carcinoma.